Details
Description
Inclusion Criteria
Exclusion Criteria
Details
Title A Phase I Study of Carboplatin/Paclitaxel/CTEP-Supplied Bevacizumab (NSC #704865, IND #7921) and CTEP-Supplied Agent ABT-888 (NSC#737664, IND #77840) in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube or primary peritoneal cancer
IRB GOG9923
CC 853
Hospital Hillcrest, Main Campus
Stage Stage 2, Stage 3, Stage 4
Phase Phase 1
Disease Fallopian Tube, Gynecologic, Ovarian, Peritoneal
Drug ABT-888, Bevacizumab , Carboplatin, Paclitaxel
